Exploring the 1,3-benzoxazine chemotype for cannabinoid receptor 2 as a promising anti-cancer therapeutic
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Exploring the 1,3-benzoxazine chemotype for cannabinoid receptor 2 as a promising anti-cancer therapeutic
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume 259, Issue -, Pages 115647
Publisher
Elsevier BV
Online
2023-07-14
DOI
10.1016/j.ejmech.2023.115647
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Structural basis of selective cannabinoid CB2 receptor activation
- (2023) Xiaoting Li et al. Nature Communications
- Platelet-Derived miR-126-3p Directly Targets AKT2 and Exerts Anti-Tumor Effects in Breast Cancer Cells: Further Insights in Platelet-Cancer Interplay
- (2022) Matteo Sibilano et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cannabinoid CB2 receptors are upregulated via bivalent histone modifications and control primary afferent input to the spinal cord in neuropathic pain
- (2022) Krishna Ghosh et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Tumor Necrosis Factor α: Taking a Personalized Road in Cancer Therapy
- (2022) Adit Ben-Baruch Frontiers in Immunology
- Correction to: Cannabinoid receptor 2 activation alleviates diabetes-induced cardiac dysfunction, inflammation, oxidative stress, and fibrosis
- (2022) Mohanraj Rajesh et al. GeroScience
- Endocannabinoids and cortical plasticity: CB1R as a possible regulator of the excitation/inhibition balance in health and disease
- (2021) Lucas J.A. Durieux et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Molecular Mechanism of Autophagy and Its Regulation by Cannabinoids in Cancer
- (2021) Xin Chien Lee et al. Cancers
- Inactivation of the CB 2 receptor accelerated the neuropathological deterioration in TDP‐43 transgenic mice, a model of amyotrophic lateral sclerosis
- (2021) Carmen Rodríguez‐Cueto et al. BRAIN PATHOLOGY
- Cannabinoids pharmacological effects are beyond the palliative effects: CB2 cannabinoid receptor agonist induced cytotoxicity and apoptosis in human colorectal cancer cells (HT-29)
- (2021) Aylar Alenabi et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Potent T cell mediated anti‐inflammatory role of the selective CB2 agonist lenabasum in multiple sclerosis
- (2021) Marta Tiberi et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- The Role of Chronic Inflammation in the Development of Breast Cancer
- (2021) David N. Danforth Cancers
- ERK: A Double-Edged Sword in Cancer. ERK-Dependent Apoptosis as a Potential Therapeutic Strategy for Cancer
- (2021) Reiko Sugiura et al. Cells
- The Peripheral Cannabinoid Receptor Type 1 (CB1) as a Molecular Target for Modulating Body Weight in Man
- (2021) Saoirse Elizabeth O’Sullivan et al. MOLECULES
- Cannabinoids in Breast Cancer: Differential Susceptibility According to Subtype
- (2021) Cristina Ferreira Almeida et al. MOLECULES
- A peripheral CB2 cannabinoid receptor mechanism suppresses chemotherapy-induced peripheral neuropathy
- (2021) Xiaoyan Lin et al. PAIN
- Activation and Signaling Mechanism Revealed by Cannabinoid Receptor-Gi Complex Structures
- (2020) Tian Hua et al. CELL
- Cryo-EM Structure of the Human Cannabinoid Receptor CB2-Gi Signaling Complex
- (2020) Changrui Xing et al. CELL
- Activation of CB2R with AM1241 ameliorates neurodegeneration via the Xist/miR‐133b‐3p/Pitx3 axis
- (2020) Xiaolie He et al. JOURNAL OF CELLULAR PHYSIOLOGY
- De Novo Drug Design of Targeted Chemical Libraries Based on Artificial Intelligence and Pair-Based Multiobjective Optimization
- (2020) Alberga Domenico et al. Journal of Chemical Information and Modeling
- Activation of cannabinoid receptor 2 protects rat hippocampal neurons against Aβ-induced neuronal toxicity
- (2020) Jingfu Zhao et al. NEUROSCIENCE LETTERS
- Crystal Structure of the Human Cannabinoid Receptor CB2
- (2019) Xiaoting Li et al. CELL
- Celiac Disease and Bone Health in Children and Adolescents: A Systematic Review and Meta-Analysis
- (2019) Michael V. Fedewa et al. JOURNAL OF CLINICAL DENSITOMETRY
- The Endocannabinoid/Endovanilloid System in Bone: From Osteoporosis to Osteosarcoma
- (2019) Rossi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- CB2 Cannabinoid receptor agonist ameliorates novel object recognition but not spatial memory in transgenic APP/PS1 mice
- (2019) Chao Li et al. NEUROSCIENCE LETTERS
- Prediction and Experimental Confirmation of Novel Peripheral Cannabinoid-1 Receptor Antagonists
- (2019) Shayma El-Atawneh et al. Journal of Chemical Information and Modeling
- Antitumor Activity of Abnormal Cannabidiol and Its Analog O-1602 in Taxol-Resistant Preclinical Models of Breast Cancer
- (2019) Andrea Tomko et al. Frontiers in Pharmacology
- Targeting glial cannabinoid CB2 receptors to delay the progression of the pathological phenotype in TDP-43 (A315T) transgenic mice, a model of amyotrophic lateral sclerosis
- (2018) Francisco Espejo-Porras et al. BRITISH JOURNAL OF PHARMACOLOGY
- Anti-Proliferative Properties and Proapoptotic Function of New CB2 Selective Cannabinoid Receptor Agonist in Jurkat Leukemia Cells
- (2018) Antonella Capozzi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Down-Expression of ACE and IDE Exacerbates Exogenous Amyloid-β Neurotoxicity in CB2R–/– Mice
- (2018) Lin Wang et al. JOURNAL OF ALZHEIMERS DISEASE
- Intra-articular treatment options for knee osteoarthritis
- (2018) Ian A. Jones et al. Nature Reviews Rheumatology
- ChEMBL: towards direct deposition of bioassay data
- (2018) David Mendez et al. NUCLEIC ACIDS RESEARCH
- (−)-β-Caryophyllene, a CB2 Receptor-Selective Phytocannabinoid, Suppresses Motor Paralysis and Neuroinflammation in a Murine Model of Multiple Sclerosis
- (2017) Thaís Alberti et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in Disease
- (2017) Debra A. Kendall et al. Frontiers in Cellular Neuroscience
- Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity
- (2017) Marjolein Soethoudt et al. Nature Communications
- Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target
- (2017) Tommaso Cassano et al. Frontiers in Neuroscience
- Bladder cancer cell growth and motility implicate cannabinoid 2 receptor-mediated modifications of sphingolipids metabolism
- (2017) Arianna Bettiga et al. Scientific Reports
- The novel, orally available and peripherally restricted selective cannabinoid CB2 receptor agonist LEI-101 prevents cisplatin-induced nephrotoxicity
- (2016) Partha Mukhopadhyay et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cannabinoid Type 2 Receptors Mediate a Cell Type-Specific Plasticity in the Hippocampus
- (2016) A. Vanessa Stempel et al. NEURON
- Potential of the cannabinoid CB2 receptor as a pharmacological target against inflammation in Parkinson's disease
- (2016) Yolanda Gómez-Gálvez et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Bone Cell-autonomous Contribution of Type 2 Cannabinoid Receptor to Breast Cancer-induced Osteolysis
- (2015) Antonia Sophocleous et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Chronic activation of CB2 cannabinoid receptors in the hippocampus increases excitatory synaptic transmission
- (2015) Jimok Kim et al. JOURNAL OF PHYSIOLOGY-LONDON
- Role of Cannabinoid Receptor CB2 in HER2 Pro-oncogenic Signaling in Breast Cancer
- (2015) Eduardo Pérez-Gómez et al. JNCI-Journal of the National Cancer Institute
- Regulation of inflammation and proliferation of human bladder carcinoma cells by type-1 and type-2 cannabinoid receptors
- (2015) Valeria Gasperi et al. LIFE SCIENCES
- Activation of cannabinoid CB2 receptors reduces hyperalgesia in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis
- (2015) Weisi Fu et al. NEUROSCIENCE LETTERS
- The Vilsmeier–Haack formylation of 2,3-dihydro-4H-1,3-benzoxazin-4-ones and isomeric 1,2-dihydro-4H-3,1-benzoxazin-4-ones: an effective approach to functionalized 2H-/4H-chromenes and tetrahydroacridines
- (2015) Oleg K. Farat et al. TETRAHEDRON
- Role of Cannabinoid Receptor CB2 in HER2 Pro-oncogenic Signaling in Breast Cancer
- (2015) Eduardo Pérez-Gómez et al. JNCI-Journal of the National Cancer Institute
- 2-Arachidonoylglycerol modulates human endothelial cell/leukocyte interactions by controlling selectin expression through CB1 and CB2 receptors
- (2014) Valeria Gasperi et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Targeting CB2-GPR55 Receptor Heteromers Modulates Cancer Cell Signaling
- (2014) Estefanía Moreno et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Synthesis, ex vivo and in silico studies of 3-cyano-2-pyridone derivatives with vasorelaxant activity
- (2013) Fernando Hernández et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments
- (2013) G. Madhavi Sastry et al. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
- Phenotypic Switch in Blood: Effects of Pro-Inflammatory Cytokines on Breast Cancer Cell Aggregation and Adhesion
- (2013) Yue Geng et al. PLoS One
- Discovery of S-777469: An orally available CB2 agonist as an antipruritic agent
- (2012) Masahide Odan et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice
- (2012) Ana María Martín-Moreno et al. Journal of Neuroinflammation
- Strategies of multi-objective optimization in drug discovery and development
- (2011) Orazio Nicolotti et al. Expert Opinion on Drug Discovery
- Discovery and Optimization of 1-(4-(Pyridin-2-yl)benzyl)imidazolidine-2,4-dione Derivatives As a Novel Class of Selective Cannabinoid CB2 Receptor Agonists
- (2011) Mario van der Stelt et al. JOURNAL OF MEDICINAL CHEMISTRY
- Reorganizing the protein space at the Universal Protein Resource (UniProt)
- (2011) NUCLEIC ACIDS RESEARCH
- Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition
- (2010) María M Caffarel et al. Molecular Cancer
- Jalview Version 2--a multiple sequence alignment editor and analysis workbench
- (2009) A. M. Waterhouse et al. BIOINFORMATICS
- CHARMM: The biomolecular simulation program
- (2009) B. R. Brooks et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
- Selective CB2 Receptor Agonism Protects Central Neurons from Remote Axotomy-Induced Apoptosis through the PI3K/Akt Pathway
- (2009) M. T. Viscomi et al. JOURNAL OF NEUROSCIENCE
- CANnabinoid Receptor Type 2 Activation Induces a Microglial Anti-Inflammatory Phenotype and Reduces Migration via MKP Induction and ERK Dephosphorylation
- (2009) Edgar Alfonso Romero-Sandoval et al. Molecular Pain
- CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways
- (2008) Fabrizio Montecucco et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- CHARMM-GUI: A web-based graphical user interface for CHARMM
- (2008) Sunhwan Jo et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
- Cannabinoid CB2receptors in the gastrointestinal tract: a regulatory system in states of inflammation
- (2007) K L Wright et al. BRITISH JOURNAL OF PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started